A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Thermo Fisher Scientific (TMO): Evaluating Valuation After $5 Billion Share Buyback Announcement - simplywall.st
Thermo Fisher Scientific (TMO): Evaluating Valuation After $5 Billion Share Buyback Announcement simplywall.st
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation Nasdaq
Is Agilent Technologies, Inc.'s (NYSE:A) Recent Stock Performance Tethered To Its Strong Fundamentals? - Yahoo Finance
Is Agilent Technologies, Inc.'s (NYSE:A) Recent Stock Performance Tethered To Its Strong Fundamentals? Yahoo Finance
Waters Corporation (WAT) Slipped Following the Acquisition Announcement - Insider Monkey
Waters Corporation (WAT) Slipped Following the Acquisition Announcement Insider Monkey
Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq
Barclays Maintains Illumina (ILMN) Underweight Recommendation Nasdaq
Can Mixed Fundamentals Have A Negative Impact on Lonza Group AG (VTX:LONN) Current Share Price Momentum? - Yahoo Finance
Can Mixed Fundamentals Have A Negative Impact on Lonza Group AG (VTX:LONN) Current Share Price Momentum? Yahoo Finance
Thermo Fisher Scientific Showcases Enhanced Accelerator™ Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025 - Business Wire
Thermo Fisher Scientific Showcases Enhanced Accelerator™ Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025 Business Wire
Lonza confirms "long-term commercial supply agreement" at U.S. biologic drug site - Investing.com
Lonza confirms "long-term commercial supply agreement" at U.S. biologic drug site Investing.com
Compact Design, Big Impact: Tridek-One Therapeutics Leverages MyGlo® to Accelerate Discovery of Immunomodulating Treatments
Tridek-One Therapeutics, a biotech firm based in Paris, adopted the MyGlo® Reagent Reader to enhance their workflow for developing CD31 checkpoint therapies. This compa...
What Thermo Fisher Scientific (TMO)'s OpenAI Partnership Could Mean for Drug Development Innovation - Yahoo Finance
What Thermo Fisher Scientific (TMO)'s OpenAI Partnership Could Mean for Drug Development Innovation Yahoo Finance